会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明授权
    • Drug complex
    • 药物复合体
    • US06458347B1
    • 2002-10-01
    • US09172085
    • 1998-10-14
    • Shuichi SugawaraMasahiro KajikiHiroshi KuriyamaNobuya Kitaguchi
    • Shuichi SugawaraMasahiro KajikiHiroshi KuriyamaNobuya Kitaguchi
    • A61K3177
    • A61K47/61A61K47/60
    • Disclosed is a drug complex of a drug having a hydroxyl group, which is capable of controlling the rate of the release of the drug therefrom in blood, the drug complex being represented by the following formula (1): A—B—C  (1) wherein A represents at least one carrier selected from the group consisting of saccharides each having a carboxyl group, polyethylene glycols each having a carboxyl group, aliphatic carboxylic acids each having a carboxyl group, and derivatives thereof each having a carboxyl group; B represents at least one spacer comprised of a compound having a amino group and a carboxyl group; C represents at least one drug having a hydroxyl group, wherein the carrier A is bonded to the spacer B through an amide bond formed between the carboxyl group of the carrier A and the amino group of the spacer B; and the spacer B is bonded to the drug C through an ester bond formed between the carboxyl group of the spacer B and the hydroxyl group of the drug C.
    • 公开了具有羟基的药物的药物复合物,其能够控制药物在血液中的释放速率,药物复合物由下式(1)表示:其中A表示至少一种载体 选自具有羧基的糖类,各自具有羧基的聚乙二醇,各自具有羧基的脂肪族羧酸,以及各自具有羧基的衍生物; B表示至少一个由具有氨基和羧基的化合物组成的间隔物; C表示至少一种具有羟基的药物,其中载体A通过形成在载体A的羧基和间隔基B的氨基之间的酰胺键与间隔基B结合; 并且间隔物B通过在间隔物B的羧基和药物C的羟基之间形成的酯键与药物C结合。
    • 5. 发明授权
    • Abrasing apparatus using magnetic abrasive powder
    • 使用磁性研磨粉的磨耗装置
    • US4730418A
    • 1988-03-15
    • US930151
    • 1986-11-12
    • Shuichi SugawaraHisatsugu KajiMasaaki Shimada
    • Shuichi SugawaraHisatsugu KajiMasaaki Shimada
    • B24B31/02B24B31/112B24B31/03
    • B24B31/112B24B31/0224
    • An abrasing apparatus including an annular barrel having an upper opening. The barrel is rotated around an exciting coil and is filled with magnetic abrasive powder which is arranged by magnetic flux generated by the exciting coil to form magnetic brush. A work is embedded into the magnetic brush. The work is rotated together with a spindle and the barrel is rotated so that the surface of the work is abrased by the magnetic brush. A bottom magnetic pole, a lateral magnetic pole and an upper magnetic pole are disposed in an inner periphery in the barrel in the proximity to the exciting coil and the strong magnetic brush is locally formed therein. The side portion of the work is located in the local magnetic brush, and the bottom, side and upper surfaces of the work are abrased like a mirror surface.
    • 一种磨损装置,包括具有上部开口的环形筒。 桶围绕励磁线圈旋转,并填充有磁性磨料粉末,该磨料粉末由励磁线圈产生的磁通量排列,形成磁刷。 一个工作嵌入到磁刷中。 工件与主轴一起旋转,并且筒被旋转,使得工件的表面被磁刷磨损。 底部磁极,横向磁极和上部磁极设置在枪管内部的靠近励磁线圈的内周中,强磁性电刷局部地形成在其中。 工件的侧面部分位于局部磁刷中,工件的底面,侧面和上表面像镜面一样磨损。
    • 6. 发明授权
    • Body fluid compatible and biocompatible resin
    • 体液相容性和生物相容性树脂
    • US07863408B2
    • 2011-01-04
    • US11028185
    • 2005-01-04
    • Shuichi Sugawara
    • Shuichi Sugawara
    • C08G65/34
    • C08G65/48A61K47/60A61L27/18A61L31/18A61L33/068C08G65/22C08G65/329C08L71/02C08L2203/02
    • A body fluid compatible and biocompatible resin for use in a medical treatment involving a contact of said resin with at least one member selected from the group consisting of a body fluid and a biological tissue, which comprises at least one substituted oxyalkylene polymer having a weight average molecular weight of from 1,000 to 1,000,000 and represented by the following formula (1): wherein each of R1, R2 and R3 independently represents a hydrogen atom or a —CH2R4 group, and each R4 independently represents a hydroxyl group or a —OR5 group (wherein R5 represents a group selected from the group consisting of a C1-C10 aliphatic hydrocarbyl group, a C6-C10 aryl group, a —R6COOH group and a derivative thereof, and a —CH2—O—CH2—CH(OH)—CH2—OR7 group, wherein R6 represents a C1-C10 aliphatic hydrocarbylene group and R7 represents a C1-C10 aliphatic hydrocarbyl group or a C6-C10 aryl group), provided that all of R1, R2, and R3 are not simultaneously hydrogen atoms; and 10≦x≦10,000 and 0≦y≦10,000.
    • 一种体液相容性和生物相容性树脂,用于涉及所述树脂与选自体液和生物组织中的至少一种的接触的药物治疗,其包含至少一种具有重量平均值的取代的氧化烯聚合物 分子量为1,000〜1,000,000,由下式(1)表示:其中,R 1,R 2和R 3各自独立地表示氢原子或-CH 2 R 4基,R 4各自独立地表示羟基或-OR 5基( 其中R5表示选自C1-C10脂族烃基,C6-C10芳基,-R6COOH基及其衍生物的基团和-CH2-O-CH2-CH(OH)-CH2 -OR7基团,其中R6表示C1-C10脂族亚烃基,R7表示C1-C10脂族烃基或C6-C10芳基),条件是R1,R2和R3全部不同时为氢原子; 和10≦̸ x≦̸ 10,000和0≦̸ y≦̸ 10,000。
    • 9. 发明授权
    • Production method of 11-sugar sialylglycopeptide
    • 11-糖唾液酸糖肽的制备方法
    • US08809496B2
    • 2014-08-19
    • US13394197
    • 2010-09-03
    • Shuichi SugawaraKenji Osumi
    • Shuichi SugawaraKenji Osumi
    • C07K9/00C07K1/30C07K1/16
    • C07K7/06C07K9/00C08B37/0063
    • It is an object of the present invention to provide a method for producing an 11-sugar sialylglycopeptide easily and with good yield and a high degree of purity on an industrial scale from defatted bird egg yolks. The present invention provides a production method of an 11-sugar sialylglycopeptide. More specifically, the present invention provides a production method of an 11-sugar sialylglycopeptide comprising: an extraction step of extracting defatted bird egg yolks with water or a salt solution to obtain a liquid extract of a glycopeptide, a precipitation step of adding the liquid extract to a water-soluble organic solvent to precipitate the glycopeptide, and a desalting step of desalting the precipitate.
    • 本发明的一个目的是提供一种从脱脂鸟蛋黄制成工业规模的11-糖唾液酸糖肽的方法,其制备方法良好,产率高,纯度高。 本发明提供了11-糖唾液酸糖肽的制备方法。 更具体地说,本发明提供了11-糖唾液酸糖肽的制造方法,包括:提取步骤,用水或盐溶液提取脱脂鸟蛋黄,得到糖肽的液体提取物,添加液体提取物的沉淀步骤 向水溶性有机溶剂中沉淀糖肽,以及脱盐脱盐步骤。
    • 10. 发明申请
    • Body fluid compatible and biocompatible resin
    • 体液相容性和生物相容性树脂
    • US20050113560A1
    • 2005-05-26
    • US11028185
    • 2005-01-04
    • Shuichi Sugawara
    • Shuichi Sugawara
    • A61K47/48A61L27/18A61L31/18A61L33/06C08G65/22C08G65/329C08G65/48C08L71/02C08G65/34
    • C08G65/48A61K47/60A61L27/18A61L31/18A61L33/068C08G65/22C08G65/329C08L71/02C08L2203/02
    • A body fluid compatible and biocompatible resin for use in a medical treatment involving a contact of said resin with at least one member selected from the group consisting of a body fluid and a biological tissue, which comprises at least one substituted oxyalkylene polymer having a weight average molecular weight of from 1,000 to 1,000,000 and represented by the following formula (1): wherein each of R1, R2 and R3 independently represents a hydrogen atom or a —CH2R4 group, and each R4 independently represents a hydroxyl group or a —OR5 group (wherein R5 represents a group selected from the group consisting of a C1-C10 aliphatic hydrocarbyl group, a C6-C10 aryl group, a —R6COOH group and a derivative thereof, and a —CH2—O—CH2—CH(OH)—CH2—OR7 group, wherein R6 represents a C1-C10 aliphatic hydrocarbylene group and R7 represents a C1-C10 aliphatic hydrocarbyl group or a C6-C10 aryl group), provided that all of R1, R2, and R3 are not simultaneously hydrogen atoms; and 10≦x≦10,000 and 0≦y≦10,000.
    • 一种体液相容性和生物相容性树脂,用于涉及所述树脂与选自体液和生物组织中的至少一种的接触的药物治疗,其包含至少一种具有重量平均值的取代的氧化烯聚合物 分子量为1,000〜1,000,000,由下式(1)表示:其中R 1,R 2和R 3各自独立地为 表示氢原子或-CH 2 R 4 R 4基团,并且每个R 4独立地表示羟基或-OR 5个基团(其中R 5表示选自C 1 -C 10脂肪族烃基的基团, C 6 -C 10芳基,-OR 6 COOH基团及其衍生物,和-CH 2, -O-CH 2 -CH(OH)-CH 2 - , - 7组,其中R 6, SUP>表示C 1 -C 3 10脂族亚烃基和R 7表示C 1 -C 10脂族烃基或C 6 - / SUB> -C 10芳基),条件是所有的R 1,R 2和R 3均为 >不是同时是氢原子; 并且10 <= x <= 10,000且0 <= y <= 10,000。